Skip to main content

Table 3 Gene sets enrichment analysis of high METTL14 mRNA expression level in the ccRCC cohort

From: Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma

Gene set name

NES

NOM p-val

FDR q-val

KEGG_ERBB_SIGNALING_PATHWAY

2.346

0.000

0.001

KEGG_MAPK_SIGNALING_PATHWAY

2.384

0.000

0.001

KEGG_MTOR_SIGNALING_PATHWAY

2.295

0.000

0.001

KEGG_PATHWAYS_IN_CANCER

2.279

0.000

0.001

KEGG_RENAL_CELL_CARCINOMA

2.279

0.000

0.001

KEGG_TGF_BETA_SIGNALING_PATHWAY

2.284

0.000

0.001

KEGG_WNT_SIGNALING_PATHWAY

2.312

0.000

0.001

  1. NES normalized enrichment score, NOM nominal, FDR false discovery rate. Gene sets with NOM p-val < 0.01 and FDR q-val < 0.01 are considered as significant